Some Common Medicinal Plants with Antidiabetic Activity, Known and Available in Europe (A Mini-Review)
| cris.virtual.author-orcid | 0000-0003-2600-8935 | |
| cris.virtualsource.author-orcid | c142ede6-209f-4499-abc4-64cfd81f296f | |
| dc.abstract.en | Diabetes is a metabolic disease that affected 9.3% of adults worldwide in 2019. Its co-occurrence is suspected to increase mortality from COVID-19. The treatment of diabetes is mainly based on the long-term use of pharmacological agents, often expensive and causing unpleasant side effects. There is an alarming increase in the number of pharmaceuticals taken in Europe. The aim of this paper is to concisely collect information concerning the few antidiabetic or hypoglycaemic raw plant materials that are present in the consciousness of Europeans and relatively easily accessible to them on the market and sometimes even grown on European plantations. The following raw materials are discussed in this mini-review: Morus alba L., Cinnamomum zeylanicum J.Presl, Trigonella foenum-graecum L., Phaseolus vulgaris L., Zingiber officinale Rosc., and Panax ginseng C.A.Meyer in terms of scientifically tested antidiabetic activity and the presence of characteristic biologically active compounds and their specific properties, including antioxidant properties. The characteristics of these raw materials are based on in vitro as well as in vivo studies: on animals and in clinical studies. In addition, for each plant, the possibility to use certain morphological elements in the light of EFSA legislation is given. | |
| dc.affiliation | Wydział Nauk o Żywności i Żywieniu | |
| dc.affiliation.institute | Katedra Technologii Gastronomicznej i Żywności Funkcjonalnej | |
| dc.contributor.author | Przeor, Monika | |
| dc.date.access | 2026-03-25 | |
| dc.date.accessioned | 2026-03-25T13:57:51Z | |
| dc.date.available | 2026-03-25T13:57:51Z | |
| dc.date.copyright | 2022-01-04 | |
| dc.date.issued | 2022 | |
| dc.description.abstract | <jats:p>Diabetes is a metabolic disease that affected 9.3% of adults worldwide in 2019. Its co-occurrence is suspected to increase mortality from COVID-19. The treatment of diabetes is mainly based on the long-term use of pharmacological agents, often expensive and causing unpleasant side effects. There is an alarming increase in the number of pharmaceuticals taken in Europe. The aim of this paper is to concisely collect information concerning the few antidiabetic or hypoglycaemic raw plant materials that are present in the consciousness of Europeans and relatively easily accessible to them on the market and sometimes even grown on European plantations. The following raw materials are discussed in this mini-review: Morus alba L., Cinnamomum zeylanicum J.Presl, Trigonella foenum-graecum L., Phaseolus vulgaris L., Zingiber officinale Rosc., and Panax ginseng C.A.Meyer in terms of scientifically tested antidiabetic activity and the presence of characteristic biologically active compounds and their specific properties, including antioxidant properties. The characteristics of these raw materials are based on in vitro as well as in vivo studies: on animals and in clinical studies. In addition, for each plant, the possibility to use certain morphological elements in the light of EFSA legislation is given.</jats:p> | |
| dc.description.accesstime | at_publication | |
| dc.description.bibliography | il., bibliogr. | |
| dc.description.finance | publication_nocost | |
| dc.description.financecost | 0,00 | |
| dc.description.if | 4,6 | |
| dc.description.number | 1 | |
| dc.description.points | 100 | |
| dc.description.version | final_published | |
| dc.description.volume | 15 | |
| dc.identifier.doi | 10.3390/ph15010065 | |
| dc.identifier.issn | 1424-8247 | |
| dc.identifier.uri | https://sciencerep.up.poznan.pl/handle/item/7939 | |
| dc.identifier.weblink | https://www.mdpi.com/1424-8247/15/1/65 | |
| dc.language | en | |
| dc.relation.ispartof | Pharmaceuticals | |
| dc.relation.pages | art. 65 | |
| dc.rights | CC-BY | |
| dc.sciencecloud | nosend | |
| dc.share.type | OPEN_JOURNAL | |
| dc.subject.en | antidiabetic | |
| dc.subject.en | hypoglycaemic activity | |
| dc.subject.en | medicinal plants | |
| dc.subject.en | white mulberry | |
| dc.subject.en | fenugreek | |
| dc.subject.en | cinnamon | |
| dc.subject.en | ginseng | |
| dc.subject.en | ginger | |
| dc.subject.en | common bean | |
| dc.subject.en | diabetes | |
| dc.subtype | ReviewArticle | |
| dc.title | Some Common Medicinal Plants with Antidiabetic Activity, Known and Available in Europe (A Mini-Review) | |
| dc.type | JournalArticle | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 1 | |
| oaire.citation.volume | 15 |